Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 29

1.

MicroRNA dysregulation in cancer: diagnostics, monitoring and therapeutics. A comprehensive review.

Iorio MV, Croce CM.

EMBO Mol Med. 2012 Mar;4(3):143-59. doi: 10.1002/emmm.201100209. Epub 2012 Feb 20. Review.

2.

Review focus on the role of microRNA in cardiovascular biology and disease.

Thum T, Mayr M.

Cardiovasc Res. 2012 Mar 15;93(4):543-4. doi: 10.1093/cvr/cvs085. Epub 2012 Feb 7. No abstract available.

3.

The response to and repair of RAG-mediated DNA double-strand breaks.

Helmink BA, Sleckman BP.

Annu Rev Immunol. 2012;30:175-202. doi: 10.1146/annurev-immunol-030409-101320. Epub 2012 Jan 3. Review.

4.

miR-125b and miR-155 contribute to BCL2 repression and proliferation in response to CD40 ligand (CD154) in human leukemic B-cells.

Willimott S, Wagner SD.

J Biol Chem. 2012 Jan 20;287(4):2608-17. doi: 10.1074/jbc.M111.285718. Epub 2011 Dec 2.

5.

Mutator activity induced by microRNA-155 (miR-155) links inflammation and cancer.

Tili E, Michaille JJ, Wernicke D, Alder H, Costinean S, Volinia S, Croce CM.

Proc Natl Acad Sci U S A. 2011 Mar 22;108(12):4908-13. doi: 10.1073/pnas.1101795108. Epub 2011 Mar 7.

6.

Nrf2 regulates chronic lung inflammation and B-cell responses to nontypeable Haemophilus influenzae.

Lugade AA, Vethanayagam RR, Nasirikenari M, Bogner PN, Segal BH, Thanavala Y.

Am J Respir Cell Mol Biol. 2011 Sep;45(3):557-65. doi: 10.1165/rcmb.2010-0321OC. Epub 2011 Jan 7.

7.

Biological functions of microRNAs: a review.

Huang Y, Shen XJ, Zou Q, Wang SP, Tang SM, Zhang GZ.

J Physiol Biochem. 2011 Mar;67(1):129-39. doi: 10.1007/s13105-010-0050-6. Epub 2010 Oct 28. Review.

PMID:
20981514
8.

Mammalian thioredoxin reductase 1: roles in redox homoeostasis and characterization of cellular targets.

Turanov AA, Kehr S, Marino SM, Yoo MH, Carlson BA, Hatfield DL, Gladyshev VN.

Biochem J. 2010 Sep 1;430(2):285-93. doi: 10.1042/BJ20091378.

9.

MicroRNA-155 functions as an OncomiR in breast cancer by targeting the suppressor of cytokine signaling 1 gene.

Jiang S, Zhang HW, Lu MH, He XH, Li Y, Gu H, Liu MF, Wang ED.

Cancer Res. 2010 Apr 15;70(8):3119-27. doi: 10.1158/0008-5472.CAN-09-4250. Epub 2010 Mar 30.

10.

Physiological and pathological roles for microRNAs in the immune system.

O'Connell RM, Rao DS, Chaudhuri AA, Baltimore D.

Nat Rev Immunol. 2010 Feb;10(2):111-22. doi: 10.1038/nri2708. Review.

PMID:
20098459
11.

DNA double-strand breaks activate a multi-functional genetic program in developing lymphocytes.

Bredemeyer AL, Helmink BA, Innes CL, Calderon B, McGinnis LM, Mahowald GK, Gapud EJ, Walker LM, Collins JB, Weaver BK, Mandik-Nayak L, Schreiber RD, Allen PM, May MJ, Paules RS, Bassing CH, Sleckman BP.

Nature. 2008 Dec 11;456(7223):819-23. doi: 10.1038/nature07392. Epub 2008 Oct 12.

12.

Genetic disruption of the Nrf2 compromises cell-cycle progression by impairing GSH-induced redox signaling.

Reddy NM, Kleeberger SR, Bream JH, Fallon PG, Kensler TW, Yamamoto M, Reddy SP.

Oncogene. 2008 Oct 2;27(44):5821-32. doi: 10.1038/onc.2008.188. Epub 2008 Jun 9.

13.

miRNA analysis in B-cell chronic lymphocytic leukaemia: proliferation centres characterized by low miR-150 and high BIC/miR-155 expression.

Wang M, Tan LP, Dijkstra MK, van Lom K, Robertus JL, Harms G, Blokzijl T, Kooistra K, van T'veer MB, Rosati S, Visser L, Jongen-Lavrencic M, Kluin PM, van den Berg A.

J Pathol. 2008 May;215(1):13-20. doi: 10.1002/path.2333.

PMID:
18348159
14.

B-cell receptor activation induces BIC/miR-155 expression through a conserved AP-1 element.

Yin Q, Wang X, McBride J, Fewell C, Flemington E.

J Biol Chem. 2008 Feb 1;283(5):2654-62. Epub 2007 Nov 28.

15.

Requirement of bic/microRNA-155 for normal immune function.

Rodriguez A, Vigorito E, Clare S, Warren MV, Couttet P, Soond DR, van Dongen S, Grocock RJ, Das PP, Miska EA, Vetrie D, Okkenhaug K, Enright AJ, Dougan G, Turner M, Bradley A.

Science. 2007 Apr 27;316(5824):608-11.

16.

Regulation of the germinal center response by microRNA-155.

Thai TH, Calado DP, Casola S, Ansel KM, Xiao C, Xue Y, Murphy A, Frendewey D, Valenzuela D, Kutok JL, Schmidt-Supprian M, Rajewsky N, Yancopoulos G, Rao A, Rajewsky K.

Science. 2007 Apr 27;316(5824):604-8.

17.

Cell survival responses to environmental stresses via the Keap1-Nrf2-ARE pathway.

Kensler TW, Wakabayashi N, Biswal S.

Annu Rev Pharmacol Toxicol. 2007;47:89-116. Review.

PMID:
16968214
18.

ATM requirement in gene expression responses to ionizing radiation in human lymphoblasts and fibroblasts.

Innes CL, Heinloth AN, Flores KG, Sieber SO, Deming PB, Bushel PR, Kaufmann WK, Paules RS.

Mol Cancer Res. 2006 Mar;4(3):197-207.

19.

The KRAS oncogene: past, present, and future.

Kranenburg O.

Biochim Biophys Acta. 2005 Nov 25;1756(2):81-2. Epub 2005 Oct 25. Review. No abstract available.

PMID:
16269215
20.

Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles.

Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, Paulovich A, Pomeroy SL, Golub TR, Lander ES, Mesirov JP.

Proc Natl Acad Sci U S A. 2005 Oct 25;102(43):15545-50. Epub 2005 Sep 30.

Items per page

Supplemental Content

Write to the Help Desk